| 000 | 01524 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250511232528.0 | ||
| 264 | 0 | _c19910301 | |
| 008 | 199103s 0 0 fre d | ||
| 022 | _a0003-3898 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAubert, G | |
| 245 | 0 | 0 |
_a[Appearance of Escherichia coli strain with high production of cephalosporinase during treatment with an amoxicillin and clavulanic acid combination]. _h[electronic resource] |
| 260 |
_bAnnales de biologie clinique _c1990 |
||
| 300 |
_a449-54 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAmoxicillin _xadministration & dosage |
| 650 | 0 | 4 | _aAmpicillin Resistance |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCephalosporinase _xbiosynthesis |
| 650 | 0 | 4 |
_aCholecystitis _xdrug therapy |
| 650 | 0 | 4 | _aClavulanic Acid |
| 650 | 0 | 4 |
_aClavulanic Acids _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aDrug Resistance, Microbial |
| 650 | 0 | 4 |
_aEscherichia coli _xdrug effects |
| 650 | 0 | 4 |
_aEscherichia coli Infections _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _abeta-Lactamase Inhibitors |
| 700 | 1 | _aPeyle, V | |
| 700 | 1 | _aDumont, N | |
| 700 | 1 | _ael Fassi, M | |
| 700 | 1 | _aDorche, G | |
| 773 | 0 |
_tAnnales de biologie clinique _gvol. 48 _gno. 7 _gp. 449-54 |
|
| 999 |
_c2284486 _d2284486 |
||